Atlas Trials

Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital.

Clinical trial NCT02608580 · COMPLETED

Trial details

NCT number
NCT02608580
Sponsor
Brugmann University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2013-12-01
Primary completion
2018-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.